4//SEC Filing
Shah Jatin 4
Accession 0001209191-21-046589
CIK 0001503802other
Filed
Jul 12, 8:00 PM ET
Accepted
Jul 13, 6:21 PM ET
Size
4.8 KB
Accession
0001209191-21-046589
Insider Transaction Report
Form 4
Shah Jatin
EVP, Chief Medical Officer
Transactions
- Tax Payment
Common Stock
2021-07-12$9.73/sh−665$6,470→ 131,137 total
Footnotes (1)
- [F1]Represents shares withheld to satisfy the reporting person's tax obligation in connection with the vesting of 2,413 restricted stock units on July 11, 2021.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001782186
Filing Metadata
- Form type
- 4
- Filed
- Jul 12, 8:00 PM ET
- Accepted
- Jul 13, 6:21 PM ET
- Size
- 4.8 KB